SCHEMBL5368445

SCHEMBL5368445

O=C(NC(CCCc1ccccc1)C1(O)CCCNC1)c1ccc(O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 1/20 0.40
ADRB2 P07550 1/20 0.39
DPP4 P27487 2/20 0.39
HPGD P15428 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HSP90AA1 P07900 1/20 0.37
GRIN2B Q13224 4/20 0.37
HDAC1 Q13547 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
TRPV1 Q8NER1 1/20 0.35
CTSG P08311 1/20 0.35
CTRB1 P17538 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5363936 0.94 KMT2A (0.44) KMT2AMEN1SMN1; SMN2HTTADRB2
SCHEMBL5360592 0.88 KMT2A (0.43) KMT2AMEN1SMN1; SMN2HTTADRB2
SCHEMBL5360267 0.81 KMT2A (0.48) KMT2AMEN1SMN1; SMN2HTTADRB2
SCHEMBL5374718 0.74 RAB9A (0.41) KMT2AMEN1SMN1; SMN2HTTADRB2
SCHEMBL5375114 0.73 KMT2A (0.42) KMT2AMEN1SMN1; SMN2HTTDPP4
SCHEMBL5370680 0.72 KMT2A (0.44) KMT2AMEN1SMN1; SMN2HTTDPP4
SCHEMBL5363812 0.69 KMT2A (0.46) KMT2AMEN1SMN1; SMN2HTTDPP4
SCHEMBL5367875 0.68 KMT2A (0.40) KMT2AMEN1SMN1; SMN2HTTDPP4
SCHEMBL5368717 0.68 KMT2A (0.40) KMT2AMEN1SMN1; SMN2HTTDPP4
SCHEMBL24604163 0.64 SLC6A3 (0.46) KMT2AMEN1SMN1; SMN2HDAC3HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed